Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 4
1991 2
1993 1
1995 2
1996 1
1997 4
1998 4
1999 2
2000 5
2002 3
2003 2
2004 1
2005 4
2006 3
2007 3
2008 6
2009 7
2010 6
2011 5
2012 3
2013 9
2014 10
2015 6
2016 4
2017 7
2018 10
2019 5
2020 4
2021 5
2022 10
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus.
Hasni SA, Gupta S, Davis M, Poncio E, Temesgen-Oyelakin Y, Carlucci PM, Wang X, Naqi M, Playford MP, Goel RR, Li X, Biehl AJ, Ochoa-Navas I, Manna Z, Shi Y, Thomas D, Chen J, Biancotto A, Apps R, Cheung F, Kotliarov Y, Babyak AL, Zhou H, Shi R, Stagliano K, Tsai WL, Vian L, Gazaniga N, Giudice V, Lu S, Brooks SR, MacKay M, Gregersen P, Mehta NN, Remaley AT, Diamond B, O'Shea JJ, Gadina M, Kaplan MJ. Hasni SA, et al. Among authors: apps r. Nat Commun. 2021 Jun 7;12(1):3391. doi: 10.1038/s41467-021-23361-z. Nat Commun. 2021. PMID: 34099646 Free PMC article. Clinical Trial.
Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19.
Sparks R, Lau WW, Liu C, Han KL, Vrindten KL, Sun G, Cox M, Andrews SF, Bansal N, Failla LE, Manischewitz J, Grubbs G, King LR, Koroleva G, Leimenstoll S, Snow L; OP11 Clinical Staff; Chen J, Tang J, Mukherjee A, Sellers BA, Apps R, McDermott AB, Martins AJ, Bloch EM, Golding H, Khurana S, Tsang JS. Sparks R, et al. Among authors: apps r. Nature. 2023 Feb;614(7949):752-761. doi: 10.1038/s41586-022-05670-5. Epub 2023 Jan 4. Nature. 2023. PMID: 36599369
Editorial: Information Processing in the Cerebellum.
Houghton C, Isope P, Apps R, Cerminara NL. Houghton C, et al. Among authors: apps r. Front Syst Neurosci. 2021 Sep 17;15:752719. doi: 10.3389/fnsys.2021.752719. eCollection 2021. Front Syst Neurosci. 2021. PMID: 34602988 Free PMC article. No abstract available.
Cerebellar Prediction and Feeding Behaviour.
Iosif CI, Bashir ZI, Apps R, Pickford J. Iosif CI, et al. Among authors: apps r. Cerebellum. 2022 Sep 19. doi: 10.1007/s12311-022-01476-3. Online ahead of print. Cerebellum. 2022. PMID: 36121552 Review.
Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus.
Hasni S, Temesgen-Oyelakin Y, Davis M, Chu J, Poncio E, Naqi M, Gupta S, Wang X, Oliveira C, Claybaugh D, Dey A, Lu S, Carlucci P, Purmalek M, Manna ZG, Shi Y, Ochoa-Navas I, Chen J, Mukherjee A, Han KL, Cheung F, Koroleva G, Belkaid Y, Tsang JS, Apps R, Thomas DE, Heller T, Gadina M, Playford MP, Li X, Mehta NN, Kaplan MJ. Hasni S, et al. Among authors: apps r. Ann Rheum Dis. 2022 Aug 1;81(11):1576-84. doi: 10.1136/ard-2022-222658. Online ahead of print. Ann Rheum Dis. 2022. PMID: 35914929 Free PMC article.
A critical look at HLA-G.
Apps R, Gardner L, Moffett A. Apps R, et al. Trends Immunol. 2008 Jul;29(7):313-21. doi: 10.1016/ Epub 2008 Jun 4. Trends Immunol. 2008. PMID: 18538632 Review.
Behavioural significance of cerebellar modules.
Cerminara NL, Apps R. Cerminara NL, et al. Among authors: apps r. Cerebellum. 2011 Sep;10(3):484-94. doi: 10.1007/s12311-010-0209-2. Cerebellum. 2011. PMID: 20838949 Free PMC article. Review.
139 results